Viewing nowGavamin Tablets (Rebamipide)
Rebamipide 100mg
Tablet · Prescription medication
Teragen Etex Co., Ltd.

MFDS item code 200411067 · Notified 2004.06.30 · Insurance code 698500290
Improvement of gastric ulcers and gastric mucosal lesions (erosion, bleeding, etc.)
This medication is used for the treatment of gastric ulcers and is effective for improving gastric mucosal lesions such as erosion, bleeding, redness, and swelling caused by acute exacerbation of acute gastritis and chronic gastritis. Thus, it helps restore the health of the gastric mucosa and improves gastrointestinal conditions.
Rebamipide is administered orally at a dosage of 100 mg three times a day. However, in the case of gastric ulcer, it is administered in the morning, evening, and before bedtime.
This medication should not be administered to patients with a hypersensitivity to the ingredients. During the course of taking this medication, serious allergic reactions such as shocks or anaphylaxis may rarely occur. Therefore, if any adverse symptoms appear, immediately discontinue use and seek appropriate treatment. There may also be side effects of decreased white blood cell or platelet counts, so blood status should be monitored carefully. Since there is a possibility of liver function problems, if liver enzyme levels rise or jaundice symptoms appear, it is necessary to discontinue administration. Allergic reactions such as hives, rash, and itching may occur on the skin. If such symptoms appear, medication should be stopped. This medication can cause neurological symptoms such as dizziness or drowsiness, so caution is required when driving or operating machinery. Gastrointestinal symptoms may include dry mouth, constipation, abdominal distension, diarrhea, nausea, vomiting, heartburn, abdominal pain, belching, and taste disturbances. If there is a significant increase in liver enzyme levels, or if fever and rash occur simultaneously, immediately discontinue use and consult a doctor. Periodic blood tests may be necessary due to changes in platelet counts or white blood cell counts. Other symptoms may include breast pain, gynecomastia, palpitations, fever, facial flushing, tongue paralysis, cough, respiratory distress, hair loss, menstrual irregularities, and edema. Women who are pregnant or may become pregnant should only use this medication when the therapeutic benefits outweigh the risks as its safety has not been established. Additionally, since this medication can be excreted in breast milk, breastfeeding women are advised to avoid breastfeeding. The safety for children or newborns has not been fully established. Older adults may have a decreased physiological function, so attention should be paid to potential side effects such as gastrointestinal symptoms. This medication should be kept out of reach of children, and transferring it to another container is discouraged as it may cause accidents or degrade quality.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to light and should be stored in a container that does not allow light to enter. Additionally, it is important to store it at room temperature between 1°C and 30°C to maintain its efficacy.
White round film-coated tablets
Domestic use - 30 tablets/bottle, Domestic use - 300 tablets/bottle, Export use - 100 tablets/box [(10 tablets/PTP × 10)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRebamipide 100mg
Tablet · Prescription medication
Teragen Etex Co., Ltd.

Rebamipide 100mg
Tablet · Prescription medication
Korea Otsuka Pharmaceutical Co., Ltd.

Rebamipide 100mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Rebamipide 100mg
Tablet · Prescription medication
Sinphong Pharmaceutical Co., Ltd.

Rebamipide 100mg
Tablet · Prescription medication
Yuhan Corporation

Rebamipide 100mg
Tablet · Prescription medication
Jongkundang Corporation

Rebamipide 100mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.

Rebamipide 100mg
Tablet · Prescription medication
Sama Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.